ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Hydroxide → 5-[2-(Tert-butyldimethylsiloxy)ethyl]-4-chloro-7-[2-c-methyl-3,5-bis-o-(2,4-dichlorophenylmethyl)-beta-d-ribofuranosyl]-7h-pyrrolo[2,3-d]pyrimidine

HRID 915865
印刷

反応式

HRID 915865 の反応式
[O:1]([CH2:9][CH2:10][C:11]1[C:19]2[C:18]([Cl:20])=[N:17][CH:16]=[N:15][C:14]=2[NH:13][CH:12]=1)[Si:2]([C:5]([CH3:8])([CH3:7])[CH3:6])([CH3:4])[CH3:3].[OH-].[K+].COCCOCCN(CCOCCOC)CCOCCOC.[Cl:45][C:46]1[CH:51]=[C:50]([Cl:52])[CH:49]=[CH:48][C:47]=1[CH2:53][O:54][C@@H:55]1[C@@H:61]([CH2:62][O:63][CH2:64][C:65]2[CH:70]=[CH:69][C:68]([Cl:71])=[CH:67][C:66]=2[Cl:72])[O:60][C@H:57](OC)[C@:56]1([CH3:74])[OH:73]>CC#N.O.C(Cl)Cl>[O:1]([CH2:9][CH2:10][C:11]1[C:19]2[C:18]([Cl:20])=[N:17][CH:16]=[N:15][C:14]=2[N:13]([C@@H:57]2[O:60][C@H:61]([CH2:62][O:63][CH2:64][C:65]3[CH:70]=[CH:69][C:68]([Cl:71])=[CH:67][C:66]=3[Cl:72])[C@@H:55]([O:54][CH2:53][C:47]3[CH:48]=[CH:49][C:50]([Cl:52])=[CH:51][C:46]=3[Cl:45])[C@@:56]2([CH3:74])[OH:73])[CH:12]=1)[Si:2]([C:5]([CH3:6])([CH3:7])[CH3:8])([CH3:3])[CH3:4]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 14797Potassium HydroxideHCID 112414Ethanamine, 2-(2-methoxyethoxy)-N,N-bis[2-(2-methoxyethoxy)ethyl]-HCID 104952735-[2-(tert-Butyldimethylsiloxy)ethyl]-4-chloro-7H-pyrrolo[2,3-d]pyrimidineHCID 11283339Methyl 3,5-bis-O-((2,4-dichlorophenyl)methyl)-2-C-methyl-alpha-D-ribofuranoside

生成物 1

HCID 87517262
5-[2-(Tert-butyldimethylsiloxy)ethyl]-4-chloro-7-[2-c-methyl-3,5-bis-o-(2,4-dichlorophenylmethyl)-beta-d-ribofuranosyl]-7h-pyrrolo[2,3-d]pyrimidine
収率 13%

試薬・触媒・溶媒 3

HCID 962Water溶媒HCID 6342Acetonitrile溶媒2 回HCID 6344Dichloromethane溶媒

実験手順

Compound 2.3 (2.5 g, 8.00 mmol) was suspended in CH3CN (50 mL), and powdered 85% KOH, (1.3 g, 19.73 mmol) followed by TDA -1 (tris[2-(2-methoxyethoxy)ethyl]amine) (0.2 mL, 0.62 mmol) were added. After stirring at room temperature for 10 min, a freshly prepared solution of bromo sugar 2.4 (prepared from commercially available 3,5-bis-O-(2,4-dichlorophenylmethyl)-2-C-methyl-1-O-methyl-α-D-ribofuranose; (i) Helv. Chim. Acta, 1995, 78, 486; (ii) WO 02/057287, 2002) (10.1 mmol) in anhydrous acetonitrile (50 mL) was added via cannula, and the reaction stirred for 24 hr at room temperature then cooled in an ice/water bath and treated with CH2Cl2 (100 mL) and water (80 mL). The aqueous material was extracted three times with CH2Cl2, the combined organic layers were dried over Na2SO4, filtered and evaporated The crude product was purified on a silica gel column using 20% ethyl acetate/hexanes as eluent to give the desired nucleoside 2.5 (1.03 g, 13%). Further elution with 25% EtOAc/hexanes as eluent gave a mixture of the desired nucleoside 2.5 and starting base 2.3 (350 mg).

後処理

  1. additionwere added
  2. additionwas added via cannula
  3. stirringthe reaction stirred for 24 hr at room temperature
  4. temperaturethen cooled in an ice/water bath
  5. extractionThe aqueous material was extracted three times with CH2Cl2
  6. dry with materialthe combined organic layers were dried over Na2SO4
  7. filtrationfiltered
  8. customevaporated The crude product
  9. customwas purified on a silica gel column

出典と根拠

ORDレコード
ord-4609062db93b4bd8b42993573b6ab4ac
出典データセット
uspto-grants-2007_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07268119B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート